Loading...
XNYSHES
Market cap40bUSD
Dec 24, Last price  
130.56USD
1D
0.69%
1Q
-1.25%
Jan 2017
109.60%
Name

Hess Corp

Chart & Performance

D1W1MN
XNYS:HES chart
P/E
29.11
P/S
3.83
EPS
4.49
Div Yield, %
1.34%
Shrs. gr., 5y
0.62%
Rev. gr., 5y
10.69%
Revenues
10.51b
-7.18%
16,733,000,00022,747,000,00028,067,000,00031,647,000,00041,165,000,00029,569,000,00035,135,000,00038,944,000,00037,691,000,00022,284,000,00010,737,000,0006,636,000,0004,762,000,0005,466,000,0006,326,000,0006,495,000,0004,667,000,0007,473,000,00011,324,000,00010,511,000,000
Net income
1.38b
-34.06%
977,000,0001,242,000,0001,916,000,0001,832,000,0002,360,000,000740,000,0002,125,000,0001,703,000,0002,217,000,0005,052,000,0002,317,000,000-3,056,000,000-6,132,000,000-4,074,000,000-282,000,000-240,000,000-2,839,000,000890,000,0002,096,000,0001,382,000,000
CFO
3.94b
-0.05%
1,903,000,0001,840,000,0003,491,000,0003,507,000,0004,567,000,0003,046,000,0004,530,000,0004,984,000,0005,660,000,0004,870,000,0004,464,000,0001,981,000,000795,000,000945,000,0001,939,000,0001,642,000,0001,333,000,0002,890,000,0003,944,000,0003,942,000,000
Dividend
Sep 16, 20240.5 USD/sh
Earnings
Jan 29, 2025

Profile

Apollo Healthcare Corp. is a private equity firm specializing in buyouts. It prefer to invest in founder-led businesses, carve-outs of non-core assets, industry consolidation, and growth-oriented businesses. The firm prefers to invest in private label consumer staples and aviation finance and asset management companies. It prefer to have majority stake in companies. Acasta Enterprises Inc. was founded in 2015 and is based in Toronto, Canada.
URL
https://www.hess.com/
IPO date
Mar 15, 1926
Employees
500
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
10,511,000
-7.18%
11,324,000
51.53%
7,473,000
60.12%
Cost of revenue
5,521,000
7,168,000
5,303,000
Unusual Expense (Income)
NOPBT
4,990,000
4,156,000
2,170,000
NOPBT Margin
47.47%
36.70%
29.04%
Operating Taxes
733,000
1,107,000
600,000
Tax Rate
14.69%
26.64%
27.65%
NOPAT
4,257,000
3,049,000
1,570,000
Net income
1,382,000
-34.06%
2,096,000
135.51%
890,000
-131.35%
Dividends
(539,000)
(465,000)
(311,000)
Dividend yield
1.22%
1.06%
1.36%
Proceeds from repurchase of equity
(20,000)
(432,000)
925,000
BB yield
0.05%
0.98%
-4.04%
Debt
Debt current
1,051,000
224,000
606,000
Long-term debt
9,902,000
9,795,000
9,218,000
Deferred revenue
418,000
(383,000)
Other long-term liabilities
1,610,000
1,064,000
1,890,000
Net debt
9,265,000
7,533,000
7,542,000
Cash flow
Cash from operating activities
3,942,000
3,944,000
2,890,000
CAPEX
(4,108,000)
(2,725,000)
(1,747,000)
Cash from investing activities
(4,113,000)
(2,555,000)
(1,325,000)
Cash from financing activities
(627,000)
(1,106,000)
(591,000)
FCF
2,593,000
1,740,000
2,040,000
Balance
Cash
1,688,000
2,486,000
2,713,000
Long term investments
(431,000)
Excess cash
1,162,450
1,919,800
1,908,350
Stockholders' equity
3,107,000
2,290,000
1,009,000
Invested Capital
20,017,550
17,288,200
16,137,000
ROIC
22.82%
18.24%
9.71%
ROCE
22.90%
21.18%
12.38%
EV
Common stock shares outstanding
307,600
309,600
309,300
Price
144.16
1.65%
141.82
91.57%
74.03
40.23%
Market cap
44,343,616
0.99%
43,907,472
91.76%
22,897,479
42.31%
EV
54,224,616
52,081,472
31,165,479
EBITDA
7,183,000
5,859,000
3,698,000
EV/EBITDA
7.55
8.89
8.43
Interest
478,000
493,000
481,000
Interest/NOPBT
9.58%
11.86%
22.17%